GI
TEVA icon

GAMMA Investing’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

GAMMA Investing’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$481K Buy
12,134
+773
+7% +$27.6K 0.02% 720
2026
Q2 		$385K Buy
11,361
+1,859
+20% +$61.9K 0.01% 797
2026
Q1 		$286K Sell
9,502
-250
-3% -$8.04K 0.01% 876
2025
Q4 		$304K Buy
9,752
+1,408
+17% +$34.7K 0.02% 755
2025
Q3 		$169K Buy
8,344
+1,062
+15% +$18.7K 0.01% 1097
2025
Q2 		$122K Buy
7,282
+2,892
+66% +$46.7K 0.01% 1279
2025
Q1 		$67.5K Sell
4,390
-3,068
-41% -$54.8K 0.01% 1570
2024
Q4 		$164K Buy
7,458
+2,297
+45% +$41.8K 0.01% 789
2024
Q3 		$93K Buy
5,161
+1,773
+52% +$31K 0.01% 1056
2024
Q2 		$55.1K Buy
3,388
+1,741
+106% +$26.8K 0.01% 1123
2024
Q1 		$23.2K Buy
1,647
+359
+28% +$4.53K ﹤0.01% 1542
2023
Q4 		$15.6K Buy
+1,288
New +$12K ﹤0.01% 1656

Other funds holding TEVA

WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
VEM
Vann Equity Management Plano, Texas $168M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

GAMMA Investing's TEVA Position: Q3 2026 in Review

GAMMA Investing increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 6.8% in Q3 2026, buying an estimated $27.6K and bringing the position to 12,134 shares worth $481K. The position accounts for 0.02% of the portfolio, ranked #720.

GAMMA Investing first reported a position in TEVA in Q4 2023 and has held it in 12 quarters since. 10 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • GAMMA Investing held 12,134 shares of Teva Pharmaceutical Industries Limited worth $481K as of Q3 2026.
  • GAMMA Investing bought 773 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $27.6K.
  • Teva Pharmaceutical Industries Limited made up 0.02% of GAMMA Investing's portfolio in Q3 2026, its #720 holding.
  • GAMMA Investing first reported a position in Teva Pharmaceutical Industries Limited in Q4 2023 and has held it in 12 quarters since.
  • 10 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.